Hemab Therapeutics Holdings, Inc. (COAG)
39.40
-0.48
(-1.20%)
USD |
NASDAQ |
Sep 11, 16:00
39.47
+0.07
(+0.18%)
After-Hours: 20:00
Hemab Therapeutics Holdings Market Cap : 1.840B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 1.840B |
| September 10, 2026 | 1.863B |
| September 09, 2026 | 2.078B |
| September 08, 2026 | 2.082B |
| September 04, 2026 | 2.074B |
| September 03, 2026 | 2.072B |
| September 02, 2026 | 2.088B |
| September 01, 2026 | 2.056B |
| August 31, 2026 | 2.136B |
| August 28, 2026 | 2.094B |
| August 27, 2026 | 2.311B |
| August 26, 2026 | 2.297B |
| August 25, 2026 | 2.319B |
| August 24, 2026 | 2.180B |
| August 21, 2026 | 2.296B |
| August 20, 2026 | 2.251B |
| August 19, 2026 | 2.413B |
| August 18, 2026 | 2.449B |
| August 17, 2026 | 2.503B |
| August 14, 2026 | 2.566B |
| August 13, 2026 | 2.520B |
| August 12, 2026 | 2.498B |
| August 11, 2026 | 2.417B |
| August 10, 2026 | 2.329B |
| August 07, 2026 | 2.319B |
| Date | Value |
|---|---|
| August 06, 2026 | 2.436B |
| August 05, 2026 | 2.339B |
| August 04, 2026 | 2.173B |
| August 03, 2026 | 2.102B |
| July 31, 2026 | 2.221B |
| July 30, 2026 | 2.217B |
| July 29, 2026 | 2.090B |
| July 28, 2026 | 2.207B |
| July 27, 2026 | 2.353B |
| July 24, 2026 | 2.210B |
| July 23, 2026 | 2.141B |
| July 22, 2026 | 2.299B |
| July 21, 2026 | 2.255B |
| July 20, 2026 | 2.307B |
| July 17, 2026 | 2.302B |
| July 16, 2026 | 2.080B |
| July 15, 2026 | 2.023B |
| July 14, 2026 | 2.023B |
| July 13, 2026 | 1.845B |
| July 10, 2026 | 1.776B |
| July 09, 2026 | 1.737B |
| July 08, 2026 | 1.583B |
| July 07, 2026 | 1.471B |
| July 06, 2026 | 1.400B |
| July 02, 2026 | 1.448B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Apogee Therapeutics, Inc. | 10.18B |
| Arrowhead Pharmaceuticals, Inc. | 11.69B |
| Oncolytics Biotech, Inc. | 92.92M |
| Sangamo Therapeutics, Inc. | 61.52M |
| Sarepta Therapeutics, Inc. | 2.160B |
Market Cap Related Metrics
| Price to Book Value | 4.051 |
| Price | 39.40 |
| Earnings Yield | -4.04% |